Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | -73 | 0 | -25 | -8 | -6 |
| Accounts receivable | -20 | N/A | -4 | -3 | -6 |
| Other Working Capital | -52 | 33 | 23 | 29 | -7 |
| Other Operating Activity | 38 | -62 | 1 | -25 | 8 |
| Operating Cash Flow | $-107 | $-29 | $-5 | $-6 | $-12 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | 100 | -194 | 6 | -52 |
| Investing Cash Flow | $-23 | $100 | $-194 | $6 | $-52 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | 0 | 25 | N/A |
| Common Stock Issued | 1,193 | 0 | 480 | 0 | 112 |
| Other Financing Activity | -133 | -14 | -40 | -5 | 0 |
| Financing Cash Flow | $1,060 | $-14 | $440 | $20 | $112 |
| Beginning Cash Position | 344 | 288 | 47 | 27 | 18 |
| End Cash Position | 1,275 | 344 | 288 | 47 | 65 |
| Net Cash Flow | $931 | $56 | $241 | $20 | $48 |
| Free Cash Flow | |||||
| Operating Cash Flow | -107 | -29 | -5 | -6 | -12 |
| Capital Expenditure | -23 | -62 | -32 | -32 | -52 |
| Free Cash Flow | -130 | -92 | -37 | -38 | -64 |